GlassScriptPhysician profile
Joseph A Arena
NPI 1356347587
$1,259.24
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,054 · 2020: $139 · 2022: $66.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $474.99 | 2019 | |
| Abbvie INC. | $347.07 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $98.96 | 2019-2020 | |
| Amgen INC. | $97.16 | 2019-2020 | |
| Integra Lifesciences Corporation | $66.30 | 2022 | |
| Lilly USA, LLC | $49.23 | 2019-2020 | |
| Janssen Biotech, INC. | $42.16 | 2019 | |
| Celgene Corporation | $40.43 | 2019 | |
| Dermira, INC. | $22.40 | 2019 | |
| Almirall LLC | $20.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Arena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.